Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
06/1993
06/16/1993CN1073169A 乙酸衍生物 Acetic acid derivatives
06/13/1993CA2085215A1 Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level
06/10/1993WO1993010774A1 Anti-hbv pyrimidine nucleoside
06/10/1993WO1993010746A1 Suspending agents for insoluble components of cleaning compositions formed by reacting alkyl ammonium salts with anionic surfactants
06/10/1993WO1993010744A2 Process for dyeing keratin fibres using an acid ph alcoxymetephenylenediamine and compositions therefor
06/10/1993CA2124929A1 Process for dyeing keratin fibers using an acid alkoxymetaphenylenediamine and compositions therefor
06/10/1993CA2124004A1 Suspending agents for insoluble components of cleaning compositions formed by reacting alkyl ammonium salts with anionic surfactants
06/09/1993EP0545912A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use
06/09/1993EP0545594A1 Oral composition having improved tooth whitening effect
06/09/1993EP0463061B1 Controlled release delivery device for macromolecular proteins
06/09/1993CN1072842A Application of N-acetyl-L-cysteine and its derivatives in conditioning of skin wrinkles and / or atrophy
06/02/1993EP0544166A2 Cephalosporinderivatives
06/02/1993CN1072591A Oral composition having improved tooth whitening effect
06/01/1993US5215758 Controlled release matrix suppository for pharmaceuticals
06/01/1993US5215749 Cosmetic composition
05/1993
05/28/1993WO1993010765A1 Controlled release oxycodone compositions
05/27/1993WO1993010091A2 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
05/27/1993WO1993010078A1 New non ionic iodized agents for x-ray contrasting method for preparing them and galenical compositions containing them
05/27/1993CA2083345A1 Cephalosporin derivatives
05/26/1993EP0543245A1 Renin inhibiting amino acid derivatives
05/26/1993CN1072413A 氨基酸衍生物 Amino acid derivatives
05/26/1993CN1020852C New pharmaceutical preparation for oral use
05/25/1993US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome
05/23/1993CA2083409A1 Oral composition having improved tooth whitening effect
05/20/1993CA2081236A1 Amino acid derivatives
05/19/1993WO1993010079A1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them
05/19/1993EP0542363A2 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
05/19/1993CN1072173A Therapeutic agents
05/19/1993CA2100338A1 Non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them
05/18/1993US5211952 Contraceptive methods and formulations for use therein
05/18/1993CA1317945C Tricyclic pyridazopyridone derivatives
05/18/1993CA1317880C Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
05/12/1993CN1071926A Novel pyrimido (1',6':1,2) pyrido (3,4-b) indole derivatives, pharmaceutical compositions containing them and process for preparing same
05/12/1993CN1071919A Benzanilide derivatives
05/12/1993CN1071832A Pressurised aerosol compositions
05/12/1993CN1020615C Epipodophyllotoxin gluconside 4'-phosphate derivs. and pren. thereof
05/11/1993US5210085 Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
05/05/1993EP0289584B1 Wound healing and bone regeneration
05/05/1993CN1071585A Methods of treatment of motor neuron diseases using members of bdnf/nt-3/ngf family of molecule
05/05/1993CN1071577A Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
05/04/1993US5208327 Intermediates useful in a synthesis of 2-chloro-2'-deoxyadenosine
04/1993
04/29/1993WO1993008280A1 Recombitope peptides
04/29/1993WO1993008206A1 Novel 2,6-disubstituted purine derivatives
04/29/1993WO1993007853A1 Inhibition of odor formation and bacterial growth
04/29/1993CA2121844A1 Novel 2,6-disubstituted purine derivatives
04/28/1993EP0538443A1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders.
04/28/1993EP0538373A1 Anti-herpes virus and cytomegalovirus oligomers
04/28/1993EP0538335A1 Dosage form for administering a drug to effect circadian therapy.
04/28/1993EP0453525B1 Method of producing aqueous mixed-micelle solutions
04/28/1993CN1071333A Calcium receptor active molecules
04/27/1993CA1316933C Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
04/27/1993CA1316828C Compounds having anti-metastatic and/or anti-inflammatory activity
04/27/1993CA1316818C Therapeutic compositions containing tumor necrosis factor-alpha
04/21/1993EP0537139A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced.
04/21/1993EP0531328A4 Liquid antiperspirant compositions
04/21/1993EP0513183A4 Cosmetic compositions
04/21/1993EP0504372A4 Cosmetic technology
04/21/1993EP0303683B1 Amphotericin b/cholesterol sulfate composition and method
04/20/1993US5204466 Stereoselective preparation of biologically active isomer
04/15/1993WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
04/14/1993EP0536896A1 Imidazolidyl macrolides having immunosuppressive activity
04/14/1993EP0536250A1 Aerosol drug formulations
04/14/1993EP0536235A1 Pressurised aerosol compositions.
04/14/1993EP0536224A1 Antiviral agents containing heteropolytungstate
04/14/1993EP0531337A4 Liquid antiperspirant compositions
04/13/1993US5202119 Administering somatomedins
04/13/1993CA1316180C L-dopa derivatives or their acid addition salts, process for producing same and their use
04/13/1993CA1316171C Cephalosporin derivatives
04/07/1993EP0535971A1 Oil dispersions of zinc oxide
04/07/1993EP0535884A1 Use of AICA riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow
04/07/1993EP0535317A1 Drug for the treatment of agitation state and nerve dysfonction
04/07/1993EP0513200A4 Method and compositions for the synthesis of bch-189 and related compounds
04/01/1993WO1993006084A1 Benzanilide derivatives as 5-ht1d antagonists
04/01/1993WO1993005792A1 New use of acidic polysaccharide esters as anti-ulcer agents
04/01/1993WO1993005788A1 METHOD OF NEUTRALIZING IL-1 USING dsRNAs
04/01/1993WO1993005765A1 Pressurised aerosol compositions
04/01/1993WO1993005759A1 Process and kit for dyeing hair
04/01/1993CA2120027A1 Method of neutralizing il-1 using dsrnas
03/1993
03/31/1993WO1993006833A1 Use of aica riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow
03/31/1993EP0534731A1 Pressurised aerosol compositions
03/31/1993EP0534445A1 Process for the preparation of a medicament for oral or topical administration in the treatment of leishmaniasis
03/31/1993EP0534097A2 Use of NADH or NADPH against cancer or AIDS
03/31/1993EP0533834A1 Intercellular adhesion mediators
03/31/1993EP0451182B1 Pharmaceutical formulations
03/31/1993EP0269729B1 Method of preparing toxoid
03/31/1993CA2096825A1 Methods of preventing tissue damage associated with decreased blood flow by administration of aica riboside compounds
03/30/1993US5198466 Oxysulfonyl urea acat inhibitors
03/30/1993CA1315480C Phosphopeptides
03/30/1993CA1315297C Benzene-1,3-diamines; process for preparing them; intermediates and use of these benzene-1,3-diamines as coupling agents for the oxidation dyeing of keratinic fibers, especially human hair
03/30/1993CA1315274C Process for the preparation of new oxime derivatives of 3-substituted 7-aminothiazolylacetamidocephalosporanic acid
03/24/1993EP0533433A1 Use of rapamycin for the manufacture of a medicament for the treatment of immunoinflammatory diseases
03/24/1993EP0533393A1 Cosmetic composition
03/24/1993EP0533294A1 Chicken anaemia agent vaccine
03/24/1993EP0533268A1 Benzanilide derivatives as 5-HT1D antagonists
03/24/1993EP0533267A1 Benzanilide derivatives as 5-HT1D antagonists
03/24/1993CN1070192A Macrolide antibiotics and their preparation
03/24/1993CA2078801A1 Enzymatically inactive phospholipase d of corynebacterium pseudotuberculosis
03/24/1993CA2078712A1 Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation
03/23/1993CA1314876C Azithromycin dihydrate
03/19/1993CA2078507A1 Benzanilide derivatives